BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Monday, January 26, 2026
Home » Authors » Mark McCarty

Mark McCarty

Articles

ARTICLES

Economics of diabetes to fuel competition among CGM units

June 13, 2012
By Mark McCarty

72nd Annual ADA Scientific Sessions: Self-monitoring for Type 2 patients not well received

June 12, 2012
By Mark McCarty
PHILADELPHIA Makers of continuous glucose monitors and test strips typically find a welcoming audience among diabetics, but a June 9 session at this year's edition of the scientific sessions by the American Diabetes Association (ADA; Alexandria, Virginia) indicates that many physicians are not terribly impressed with self-monitoring of blood glucose (SMBG). A session on this subject featured a debate on the pros and cons, but even the advocate of SMBG sounded less than wholly enthused at the practice, arguing at one point that "a conclusive study" in support of SMBG "is still missing."
Read More

Washington roundup: CMS reposts 2006 CED draft at new site dedicated to CED

June 12, 2012
By Mark McCarty

Washington Roundup: OIG eyes manager training, but Duval cites reviewers

June 11, 2012
By Mark McCarty

Washington roundup: Device tax repeal bill clears House via vote of 270-146

June 8, 2012
By Mark McCarty
The House vote on a bill to repeal the 2.3% medical device tax passed a vote on the House floor, setting up a showdown with the Senate over the bill's reclamation of healthcare insurance subsidies as an offset to the 2.3% device tax. Also looming is a threat by the White House to veto any such bill, but a leading Democrat in the House said the Senate will never address similar legislation.
Read More

Washington roundup: Device tax repeal bill faces drag over subsidy clawback

June 7, 2012
By Mark McCarty

Washington roundup: Judge reinstates suit based on FDA inspectional data

June 6, 2012
By Mark McCarty

Washington roundup: Lasersohn sees private payers tightening standards for coverage

June 5, 2012
By Mark McCarty
Medicare receives the lion's share of attention where coverage and reimbursement are concerned, but at least one venture capitalist deeply involved in med-tech says private payers have historically been more stringent, and are becoming more so. Jack Lasersohn of the Vertical Group (Summit, New Jersey) told Medical Device Daily, "I think it is more coverage" than reimbursement that is the issue with regard to private payers. He also said this is no reflexive approach to a slippery coverage slope, stating, "I think this is a very conscious raising of the bar" on the part of private payers.
Read More

MDMA 2012 annual meeting: Paulsen: repeal of device tax unlikely before 2012 election

June 4, 2012
By Mark McCarty
WASHINGTON The House Ways and Means Committee has passed a medical device tax repeal bill by a sizable margin (see story below), but Rep. Erik Paulsen (R-Minnesota) told industry at a meeting in Washington it is unlikely that a repeal bill would be available for review in the Oval Office until after the November elections. "We have some opportunity to make some headway in the Senate," Paulsen told attendees at the Medical Device Manufacturers Association (Washington) annual meeting, but he acknowledged he does not have a good grasp of the Senate head count as it currently stands.
Read More

Brazil's Anvisa faces hurdles in shared ISO audit program

June 4, 2012
By Mark McCarty
View All Articles by Mark McCarty

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for Jan 23, 2025.
  • Today's news in brief

    BioWorld MedTech
    BioWorld MedTech briefs for Jan. 23, 2026.
  • Illustration of magnifying glass inspecting brain

    Neurotrimin unveiled as marker in intellectual disability

    BioWorld Science
    Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
  • DNA mutations or genetic disorder concept art

    Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease

    BioWorld Science

    Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...

  • Illustration of human body surrounded by DNA, cell and drug icons

    Cell/gene therapy sector now sustainable; China competition mounting

    BioWorld
    There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld MedTech
    • Today's news
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/Metabolic
    • Immune
    • Infection
    • Neurology/Psychiatric
    • NME Digest
    • Patents
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing